Showing all 4 results
Collagen Peptide , Sodium Hyaluronate , Chondroitin Sulfate and Vitamin C Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Macrodose FDC Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical survival of the intensely sensitive biological payloads.
Active Ingredient Strength Primary Clinical Function Hydrolyzed Collagen Peptides (Type I & II) 150 mg – 500 mg
(Customizable per monograph)The Structural Foundation: The massive, highly bioavailable amino acid payload required to stimulate chondrocyte proliferation and rebuild the physical cartilage matrix. Chondroitin Sulfate Sodium USP/Ph.Eur. 200 mg The Cartilage Hydrator & Shield: Prevents enzymatic cartilage degradation and draws essential water into the articular matrix for compression resistance. Sodium Hyaluronate (Hyaluronic Acid) 30 mg The Synovial Lubricant: Restores the high-viscosity, shock-absorbing properties of the joint capsule fluid. Vitamin C (Ascorbic Acid) USP/Ph.Eur. 35 mg The Biosynthetic Cofactor: The absolute mandatory catalyst required to cross-link the newly formed collagen fibers into a strong, unified matrix. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Glidant / Lubricant / Heavy Film-Coating (Engineered specifically utilizing advanced Cold-Process High-Shear Granulation. Fluffy collagen peptides are heavily densified without using destructive heat that would instantly oxidize and destroy the Vitamin C payload) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30/60 (Optimized specifically for premium retail presentation and chronic daily compliance).
Diacerein & Glucosamine Sulphate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrolytically Shielded Macrodose FDC Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical survival of the intensely hygroscopic Glucosamine salt.
Active Ingredient Strength Primary Clinical Function Diacerein USP/Ph.Eur. 50 mg The IL-1β Inhibitor: The potent, slow-acting anti-inflammatory anchor required to halt the enzymatic digestion of joint cartilage. Glucosamine Sulphate Potassium Chloride USP/Ph.Eur.
(Equivalent to Glucosamine Sulphate 750mg)750 mg The Cartilage Substrate: The massive amino-sugar payload required to stimulate proteoglycan synthesis and rebuild the articular matrix. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K-30 / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Glidant / Heavy Film-Coating (Engineered specifically utilizing advanced Low-Humidity Granulation Technology to process the sticky, highly hygroscopic Glucosamine, sealed with a dense polymer film to block environmental moisture and ensure rapid gastric dissolution of the highly insoluble Diacerein) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, continuous, long-term chronic dispensing regimens).
Divalproex sodium Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrolytically Shielded Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical survival of the intensely hygroscopic active ingredient.
Active Ingredient Strength Primary Clinical Function Divalproex Sodium USP/Ph.Eur. 250 mg (DR / ER) The Titration & Pediatric Standard: The definitive unit utilized for careful initial dose titration in adult bipolar patients or weight-based dosing for pediatric epilepsy. Divalproex Sodium USP/Ph.Eur. 500 mg (DR / ER) The Neurology Macrodose: Massive therapeutic payload utilized for the aggressive, sustained suppression of chronic complex partial seizures and acute bipolar mania. Excipients (Enteric DR Formulation) Microcrystalline Cellulose / Croscarmellose Sodium / Povidone / Methacrylic Acid Copolymer (Eudragit) / Triethyl Citrate / Titanium Dioxide Diluent / Superdisintegrant / Binder / Enteric Polymer / Plasticizer / Opaque Film (Engineered specifically utilizing advanced fluid-bed enteric coating to completely shield the highly corrosive valproate compound from the stomach, ensuring the pill only dissolves in the alkaline environment of the small intestine to prevent severe gastric bleeding and vomiting) *Pack Sizes: 10×10 Alu-Alu Blisters or Heavy-Gauge HDPE Bottles (Optimized specifically for strict chronic neurology and psychiatry dispensing regimens).
L- ornithine-L-aspartate tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical and physical stability of the highly hygroscopic amino acid salt.
Active Ingredient Strength Primary Clinical Function L-Ornithine L-Aspartate (LOLA) 150 mg / 250 mg Hepatology Maintenance Standard: Base therapeutic units for long-term chronic management of severe Non-Alcoholic Fatty Liver Disease (NAFLD), alcoholic hepatitis, and mild hyperammonemia. L-Ornithine L-Aspartate (LOLA) 500 mg Acute Detoxification Standard: High-efficacy adult therapy utilized for immediate ammonia reduction and the step-down management of Hepatic Encephalopathy following hospital discharge. Excipients Microcrystalline Cellulose / Crospovidone / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Opadry Moisture-Barrier Film Diluent / Superdisintegrant / Glidant / Film-Coating (Engineered specifically to lock out atmospheric moisture, preventing the heavy 500mg amino acid tablet from swelling, cracking, or prematurely degrading before it reaches the patient’s stomach) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, high-volume chronic hepatology dispensing regimens).
